Uric acid and oxidative stress: relative impact on cardiovascular risk?
about
Deficiency in Poly(ADP-ribose) Polymerase-1 (PARP-1) Accelerates Aging and Spontaneous Carcinogenesis in MiceAssociations between purine metabolites and clinical symptoms in schizophreniaHomeostatic imbalance of purine catabolism in first-episode neuroleptic-naïve patients with schizophreniaDifference in the action mechanism of radon inhalation and radon hot spring water drinking in suppression of hyperuricemia in miceAntioxidants, redox signaling, and pathophysiology in schizophrenia: an integrative view.Serum uric acid levels and multiple health outcomes: umbrella review of evidence from observational studies, randomised controlled trials, and Mendelian randomisation studiesUric acid as one of the important factors in multifactorial disorders--facts and controversies.Parasitological and biochemical studies on cutaneous leishmaniasis in Shara'b District, Taiz, YemenFructose and cardiometabolic disorders: the controversy will, and must, continue.Cardiovascular risk factors and total serum antioxidant capacity in healthy men and in men with coronary heart diseaseBilirubin Level is Associated with Left Ventricular Hypertrophy Independent of Blood Pressure in Previously Untreated Hypertensive PatientsAssociations between purine metabolites and monoamine neurotransmitters in first-episode psychosis.A potential role for plasma uric acid in the endothelial pathology of Plasmodium falciparum malaria.Association between serum uric acid levels and cardiovascular risk among university workers from the State of Mexico: a nested case-control study.The risk of Parkinson disease associated with urate in a community-based cohort of older adults.Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese menConsequences of PPAR(α) Invalidation on Glutathione Synthesis: Interactions with Dietary Fatty Acids.Increased serum levels of uric acid are associated with sudomotor dysfunction in subjects with type 2 diabetes mellitusSystemic markers of oxidative stress in relation to metabolic syndrome componentsRelationship Between Hyperuricemia and Cardiovascular Disease Risk Factors in a Chinese Population: A Cross-Sectional StudySerum uric acid as a prognostic marker in the setting of advanced vascular disease: a prospective study in the elderly.Effects of orange juice and hesperetin on serum paraoxonase activity and lipid profile in hyperuricemic ratsRedox control of renal function and hypertension.Relationship between Uric Acid Levels and Diagnostic and Prognostic Outcomes in Acute Heart Failure.Effects of Parsley (Petroselinum crispum) and its Flavonol Constituents, Kaempferol and Quercetin, on Serum Uric Acid Levels, Biomarkers of Oxidative Stress and Liver Xanthine Oxidoreductase Aactivity inOxonate-Induced Hyperuricemic Rats.Antioxidant therapies for the management of atrial fibrillation.Orange juice and hesperetin supplementation to hyperuricemic rats alter oxidative stress markers and xanthine oxidoreductase activity.Association of a common nonsynonymous variant in GLUT9 with serum uric acid levels in old order amish.Pharmacology of free radicals and the impact of reactive oxygen species on the testisUric acid and antioxidant effects of wine.Xanthine oxidoreductase: a journey from purine metabolism to cardiovascular excitation-contraction coupling.Camellia sinensis in asymptomatic hyperuricemia: A meta-analysis of tea or tea extract effects on uric acid levels.Postpartum development of endothelial dysfunction and oxidative stress markers in women with previous gestational diabetes mellitus.Gender differences for uric acid as predictor of hard events in patients referred for coronary angiography.Hyperuricemia has an adverse impact on the prognosis of patients with osteosarcoma.Apple, cherry, and blackcurrant increases nuclear factor kappa B activation in liver of transgenic mice.Uric acid metabolism in patients with primary gout and the metabolic syndrome.Metabolic syndrome characteristics in gout patients.Effect of moxonidine and amlodipine on serum YKL-40, plasma lipids and insulin sensitivity in insulin-resistant hypertensive patients-a randomized, crossover trial.Evaluation of reference intervals for biomarkers sensitive to alcohol consumption, excess body weight and oxidative stress.
P2860
Q21342802-0251270F-A0C4-4A99-9986-0409C31695B1Q21560779-164C2D4D-0CD8-4DD9-A349-FBCD28C0DEEBQ21562668-C6BB9B0A-0A1C-4931-BEEC-344EC773359BQ28829531-BA109B2C-E557-478C-AF29-FF0355FD31B2Q33350202-B61D3634-793D-4C85-B051-3E36B4E693C1Q33770852-4C1EA31F-7491-41DA-B030-8F3F3D8EC3E1Q33773142-DBED4CE6-1DC5-4FE3-8D07-833E7D27684FQ33869978-30273D6E-12F8-4753-B09A-75E8FAE890BEQ34023494-E7ECCECE-F987-43FD-B4BD-0CF4CC2314C2Q34087339-C103061C-3D48-4840-839D-18BD09ED6203Q34269653-D8619F19-8B92-43CD-9511-D3165866312CQ34351848-73C883AE-0078-49C2-A070-774BCF8B9493Q34563150-0151488A-D927-477D-9D10-D671F7606384Q34696478-83E298D1-66FA-4FED-B236-3CCAF3614448Q35071745-8E4048A2-C845-404C-9500-393648908D1EQ35106589-93EE6BD2-47A2-4080-84FC-947656A9E711Q35208556-BB3CB739-AEE2-461A-92B3-4C6B886D06A1Q35219367-318E5D48-84CC-4352-9C88-8453D7552EFAQ35714287-77CE18C6-525C-4633-B09B-9729BC253676Q36078408-B7C3F5C3-15FC-404D-80F3-149CD0794B6DQ36162192-AFEA0016-3BC3-45CB-9E3D-07A1DF915FDFQ36829246-49CDC3DC-EDBF-40CB-8349-8F4BCAE14822Q36970633-2BEC71E5-28D8-4845-9248-9CDC876EF911Q37184318-C8393349-B8DF-4614-9A34-0A593028ECC5Q37268110-D15914E1-38F3-4724-8E4B-F571EB6DA880Q37339307-8EED8A21-B1D3-4ECB-96D5-2DEDEE4ED85DQ37407485-141E3860-8983-4E1C-9C84-66E365F34AA9Q37426402-D249F7A6-B014-451E-BC08-54E63F847FABQ37547994-BEA081A1-B0C3-4EFE-A8EE-1A473EC50964Q37693858-C4DD88A6-274C-45B7-9EA3-C01F8BA72968Q37903030-F7BE9397-6050-445A-8CC6-58C642242D1DQ38409261-81ED8B2A-BAA9-4A56-9EF7-798FF14F5200Q39265262-5A39A5B7-97F6-4A6E-B5DC-80927D1449CBQ39922080-0039A325-3AD6-4A3F-9435-01C0BDD81865Q40634556-2A524620-2EF6-466E-9342-F8EE25F0B2FDQ42956874-CD69F9E1-AC2E-45BD-8D92-3443EB0E2CF1Q43026558-BD3135CA-74FC-4B82-9B14-1818D8F7EB06Q43026562-3AC4741E-1C90-4DD6-8016-8895A04820C3Q43169808-542DD248-E861-4119-80D1-482C70E2B33BQ43194619-2FA1BC5D-4008-4E1A-BE29-3DC1EE8B948C
P2860
Uric acid and oxidative stress: relative impact on cardiovascular risk?
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@ast
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@en
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@nl
type
label
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@ast
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@en
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@nl
prefLabel
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@ast
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@en
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@nl
P1476
Uric acid and oxidative stress: relative impact on cardiovascular risk?
@en
P2093
Juan Garcia Puig
Pasquale Strazzullo
P304
P356
10.1016/J.NUMECD.2007.02.011
P577
2007-07-01T00:00:00Z